
pmid: 17081650
On 29 December 1959 at the annual meeting of the American Physical Society at Caltech Richard Feynman delivered a lecture entitled “There's Plenty of Room at the Bottom” in which he stated “I leave to your imagination the improvement of the design to take full advantage of the properties of things on a small scale”. Feynman's statement has proven to be true, thanks to developments in nanotechnology, which are now having an impact on modern medicine. It is the intention of this Theme Issue of Advanced Drug Delivery Reviews (ADDR) to critically examine the potential biomedical application of promising nanoscale particulate materials, either in their own rights or as a component of multifunctional platforms, in the context of experimental disease detection and treatment following administration into the body. Indeed, the physical and chemical properties of a given material can significantly improve or radically change as size is down-scaled to small clusters of atoms (from a few to tens of nanometers) [1]. These include mechanical, thermal, electrical, magnetic, and light emission properties. This has led to development of an array of novel nanomaterials and nanocomposites the characteristics of which are beginning to have a paradigm-shifting impact in medicine; they are changing the foundations of disease diagnosis, monitoring and treatment, and turning promising molecular discoveries into benefits for patients (Table 1). For example, in semiconductor quantum dots (QDs), which are made of silicon and gallium arsenide core, there are discrete electronic energy levels (valance band and conduction band), but the spacing of the electronic energy levels (band gap) can be precisely controlled through variation in size [2]. When a photon, with higher energy than the energy of the band gap, hits a QD, an electron is promoted from valance band into the conduction band, leaving a hole behind. Electrons emit their excess energy as light when they recombine with holes. Since optical response is due to the excitation of single ...
Drug Delivery Systems, Nanomedicine, C000 Biological and Biomedical Sciences, Humans, Therapeutics, 530, Diagnostic Techniques and Procedures
Drug Delivery Systems, Nanomedicine, C000 Biological and Biomedical Sciences, Humans, Therapeutics, 530, Diagnostic Techniques and Procedures
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 41 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
